Observational Study Design Challenges-The Case of Fluoroquinolones and Aortic Disease - PubMed (original) (raw)
Comment
Observational Study Design Challenges-The Case of Fluoroquinolones and Aortic Disease
Raphaela Lipinsky DeGette et al. JAMA Intern Med. 2020.
No abstract available
Comment on
- Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M. Gopalakrishnan C, et al. JAMA Intern Med. 2020 Dec 1;180(12):1596-1605. doi: 10.1001/jamainternmed.2020.4199. JAMA Intern Med. 2020. PMID: 32897307 Free PMC article. - Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Dong YH, Chang CH, Wang JL, Wu LC, Lin JW, Toh S. Dong YH, et al. JAMA Intern Med. 2020 Dec 1;180(12):1587-1595. doi: 10.1001/jamainternmed.2020.4192. JAMA Intern Med. 2020. PMID: 32897358 Free PMC article.
Similar articles
- Fluoroquinolones and Aortic Disease.
Gatti M, Raschi E, De Ponti F. Gatti M, et al. JAMA Intern Med. 2021 Jun 1;181(6):881. doi: 10.1001/jamainternmed.2020.9226. JAMA Intern Med. 2021. PMID: 33646264 No abstract available. - Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths.
Lai CC, Lu CT, Kao KC, Lu MC, Ko WC, Hsueh PR. Lai CC, et al. J Microbiol Immunol Infect. 2021 Apr;54(2):182-184. doi: 10.1016/j.jmii.2021.03.002. Epub 2021 Mar 14. J Microbiol Immunol Infect. 2021. PMID: 33775552 No abstract available. - What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.
Sommet A, Bénévent J, Rousseau V, Chebane L, Douros A, Montastruc JL, Montastruc F. Sommet A, et al. J Gen Intern Med. 2019 Apr;34(4):502-503. doi: 10.1007/s11606-018-4774-2. J Gen Intern Med. 2019. PMID: 30565153 Free PMC article. No abstract available. - Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis.
Singh S, Nautiyal A. Singh S, et al. Am J Med. 2017 Dec;130(12):1449-1457.e9. doi: 10.1016/j.amjmed.2017.06.029. Epub 2017 Jul 21. Am J Med. 2017. PMID: 28739200 Review. - Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.
Latif A, Ahsan MJ, Kapoor V, Lateef N, Malik SU, Patel AD, Khan BA, Bittner M, Holmberg M. Latif A, et al. WMJ. 2020 Sep;119(3):185-189. WMJ. 2020. PMID: 33091293 Review.
Cited by
- Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis.
Chen C, Patterson B, Simpson R, Li Y, Chen Z, Lv Q, Guo D, Li X, Fu W, Guo B. Chen C, et al. Front Cardiovasc Med. 2022 Aug 9;9:949538. doi: 10.3389/fcvm.2022.949538. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36017083 Free PMC article. - Hereditary Thoracic Aortic Diseases.
Spaziani G, Surace FC, Girolami F, Bianco F, Bucciarelli V, Bonanni F, Bennati E, Arcieri L, Favilli S. Spaziani G, et al. Diagnostics (Basel). 2024 Jan 4;14(1):112. doi: 10.3390/diagnostics14010112. Diagnostics (Basel). 2024. PMID: 38201421 Free PMC article. Review. - Risk Factors for Thoracic Aortic Dissection.
Zhou Z, Cecchi AC, Prakash SK, Milewicz DM. Zhou Z, et al. Genes (Basel). 2022 Oct 7;13(10):1814. doi: 10.3390/genes13101814. Genes (Basel). 2022. PMID: 36292699 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources